Table 4. Cox-regression survival analysis of patients hospitalized with Chronic liver disease (CLD) in relation to selected clinical findings as predictors.
| Factors | CHR[95% CI ] | P-value | AHR[95% CI ] | P-value | |
|---|---|---|---|---|---|
| khat chewing history | |||||
| Yes | 0.466[0.214–1.015] | 0.055 | 0.299 [0.043–2.083] | 0.223 | |
| No | 1 | 1 | |||
| Cigarette smoking history | |||||
| Yes | 1.985[0.842–4.677] | 0.117 | 2.101[0.158–27.939] | 0.574 | |
| No | 1 | 1 | |||
| Hepatic encephalopathy | 0.011 | ||||
| Yes | 2.708 [1.252–5.859] | 11.361[2.391–53.987] | 0.002ǂ | ||
| No | 1 | 1 | |||
| HBsAg+ | 0.570[0.265–1.230] | 0.152 | 1.395[0.1502–12.959] | 0.770 | |
| Unidentified risk factor/etiology | 2.113[1.012–4.437] | 0.046 | 5.803[1.380–24.405] | 0.016ǂ | |
| Yes | 0.577 [0.078 4.261] | 0.59 | |||
| No | 1 | ||||
| MAP, mmHg | 0.973 [0.940–1.007] | 0.117 | 0.962[0.888–1.042] | 0.346 | |
| WBC, (109/L) | 1.036 [0.986–1.089] | 0.161 | 1.056[0.941–1.186] | 0.351 | |
| Hgb, g/dl | 1.010 [0.897–1.137] | 0.868 | |||
| MCV, fl | 1.005 [1.00–1.007] | <0.001 | 1.005[0.999–1.011] | 0.095 | |
| Total bilirubin, mg/dl | 1.084[1.034–1.138] | 0.001 | 1.188[1.0719–1.316] | 0.001ǂ | |
| ALT, u/l, | 1.004 [0.998–1.010] | 0.240 | 0.992 [0.981–1.004] | 0.194 | |
| Scr, mg/dl | 1.233[1.016–1.495] | 0.034 | 0.686[0.459–1.025] | 0.066 | |
| Nodular liver surface | 0.475[0.178–1.266] | 0.136 | 3.699[0.724–18.895] | 0.116 | |
| Splenomegaly | 0 .532[0.236–1.2] | 0.128 | 2.236[0.540–9.267] | 0.267 | |
| Heterogeneous echotexture | 5.906[2.484–14.044] | 0.000 | 2.645[0.403–17.358] | 0.311 | |
| In-hospital acute Complication of CLD |
|||||
| Yes | 1.607[0.752–3.432] | 0.221 | 1.886 [0.413–8.613] | 0.413 | |
| No | 1 | ||||
ALT- Alanine aminotransferase; CLD-Chronic Liver Disease; HBsAg- Hepatitis B Virus Surface Antigen; MAP- Mean Arterial Pressure, MCV-Mean Corpuscular Volume; WBC-White Blood Cell Count; Scr-Serum Creatinine
ǂ Statistically significant